about
Vaccines for measles, mumps and rubella in childrenVaccines for measles, mumps and rubella in childrenDo childhood vaccines cause thrombocytopenia?MMR vaccine and idiopathic thrombocytopaenic purpuraThe average cost of measles cases and adverse events following vaccination in industrialised countries.Safety assessment of adjuvanted vaccines: Methodological considerationsFrequently asked questions on seven rare adverse events following immunization.Management of immune thrombocytopenic purpura in children.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.Severe thrombocytopenic purpura due to rubella infection in a patient with systemic lupus erythematosus.A case of symptomatic idiopathic thrombocytopenic purpura during mumps.Acute immune thrombocytopenic purpura in infants: associated factors, clinical features, treatment and long-term outcome.Pathobiology of secondary immune thrombocytopenia.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs.Atorvastatin-related thrombocytopenic purpura.Vaccine administration and the development of immune thrombocytopenic purpura in childrenImmune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines.Investigation of daytime wetting: when is spinal cord imaging indicated?No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome.Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012Vaccine allergiesCould autoimmunity be induced by vaccination?Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.Active surveillance for adverse events following immunization.Measles vaccine: Past, present, and future.Adverse events following immunization: real causality and myths.Autoimmune reaction after anti-tetanus vaccination-description of four cases and review of the literature.Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.Use of intravenous megadose corticosteroid in a child with thrombocytopenic purpura due to mumps.Vaccinations and autoimmune diseases.A modified self-controlled case series method to examine association between multidose vaccinations and death.Investigating the assumptions of the self-controlled case series method.The methodology of self-controlled case series studies.Vaccination and anesthesia: the precautionary principle is to vaccinate.More on RotaShield and intussusception: the role of age at the time of vaccination.Adverse events of vaccines and the consequences of non-vaccination: a critical review.Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
P2860
Q24203667-C8D1262E-B9DE-4192-8C3C-1055AD3A7DEDQ24245722-51F3CC4A-8C16-4FB6-ADF2-C4E10A62E5B5Q24652460-BF4DAFB9-ED60-4307-BDD6-EE7749C53991Q24679503-177062C2-41B3-4527-AA6E-DA6D683BB82EQ24804057-5AE75A5C-F415-484D-B44F-49334B607091Q27013956-7542303B-A2EC-4035-8738-4EE056B5C194Q30234430-5F6C03C9-2CB9-4A68-B5BF-87AC75955776Q33339743-8722B10E-DA02-4F2B-BCC5-56EB2B06F6E5Q33346561-A5F93932-00EB-4847-BC88-E4FEF86D701FQ33346896-50D5E227-0475-48B8-8C76-E6E3EB16BC75Q33367304-B116EFE1-C327-46F4-8342-DD6398E801ECQ33372026-4704D67F-FE20-4A4A-B8A5-1D31BDA45999Q33383468-B7643D15-EFFC-473E-9DC8-0C381F655634Q33393732-57B58715-A8BD-4F14-881E-9945ADA296CDQ33398628-258ED02D-C645-40F4-ABF1-411BC64DE9A9Q33402096-281B99BF-7213-4B73-9E55-16FC2A75AB6CQ33405328-69BB77A4-EA0E-4E49-B9CB-EF018C7794E8Q33418883-91598A00-E362-4FAD-AD57-D2C765EF5CA0Q35193529-55AA1131-257A-4C8C-B2AB-439B94B29D57Q35273030-D605E8B3-3A9F-4794-8E09-3589F08F4583Q36154085-032B4248-9BF9-46C1-B77E-6A09EB15F151Q36478305-68E1146D-6337-407A-9E2B-4F30425F4FD1Q37473533-FA60FDDD-B2BF-47A4-8CE9-8CB3982AB54CQ37762550-FD043A7F-7B1A-4B5D-8B04-68AC09FE171DQ37919183-7378B73C-3AAE-4C6F-9EE8-D3C310A443CCQ38172268-0E8503CE-748E-42EE-852A-CED8EB8D59CFQ38560170-D75C94F8-E820-4EF1-9051-98A686406D22Q38778111-29974326-2934-4DF9-B1A2-C0C906079F7FQ38902486-36BDB17C-E7C6-4112-97DB-57A118184017Q42361533-D29D07F7-7E3A-43A9-A69C-3332B4F52338Q43848105-3770AAC3-DEC2-4710-99F8-11DEE2F0D850Q43910117-7BFB01D9-DF51-47C2-BD3A-4CDC432F675DQ44440836-200C6373-AA06-431A-A3E7-8A25F613E406Q46661122-105B98E6-34CC-4C33-9B01-68396B4374BFQ47623026-29C7CC74-2299-46EB-B8AD-B3C5191E5FC7Q48337833-8AC5229F-08B6-421F-87E1-74AE5145DFC6Q48549939-F843DA8F-E087-40F5-9494-BBEBBF260E74Q50767129-AF618B49-4E8A-425B-B2DB-0CE039F55C1AQ55160432-02E42A51-95F6-42F2-86C0-31A18E14FB88Q56795571-8CAD2EC9-D136-48C0-A561-41E4F5404F0E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Idiopathic thrombocytopenic purpura and MMR vaccine
@ast
Idiopathic thrombocytopenic purpura and MMR vaccine
@en
Idiopathic thrombocytopenic purpura and MMR vaccine.
@nl
type
label
Idiopathic thrombocytopenic purpura and MMR vaccine
@ast
Idiopathic thrombocytopenic purpura and MMR vaccine
@en
Idiopathic thrombocytopenic purpura and MMR vaccine.
@nl
prefLabel
Idiopathic thrombocytopenic purpura and MMR vaccine
@ast
Idiopathic thrombocytopenic purpura and MMR vaccine
@en
Idiopathic thrombocytopenic purpura and MMR vaccine.
@nl
P2093
P2860
P356
P1476
Idiopathic thrombocytopenic purpura and MMR vaccine
@en
P2093
P2860
P304
P356
10.1136/ADC.84.3.227
P407
P577
2001-03-01T00:00:00Z